Decrease in Fecal Calprotectin and C-reactive Protein Levels Correlate with Improved Clinical Outcomes in Patients with Moderately to Severely Active Crohn's Disease Treated with Mirikizumab

A. Charabaty,M. Kayal, C. R. Kelly,B. L. Cohen,G. D'Haens,A. Hart, F. Chan-Diehl, G. Yu, Y. Brogan,M. Protic, R. Moses, D. Fisher,S. Travis

JOURNAL OF CROHNS & COLITIS（2025）

Cited 0|Views4

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined